Brensocatib, the first FDA-approved medication to treat non-cystic fibrosis bronchiectasis, can reduce symptoms of the ...

Panelists discuss how ideal candidates for bronchiectasis surgery have localized disease on CT scan and bronchoscopy, adequate pulmonary function (orced expiratory volume in 1 second > 40%), and whose ...

Panelists discusses how the "vicious vortex model" explains bronchiectasis pathophysiology, where airway dilatation leads to mucus stagnation, chronic infections, and neutrophilic inflammation, ...

THE anesthesia and operating-room care of patients who are to be treated surgically for bronchiectasis need to be planned and carried out in a simple but logical manner if anesthesia mortality and ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. This study cohort was made up of 71.3% U.K. patients ...